Tyrosine hydroxylase is short-term regulated by the ubiquitin-proteasome system in PC12 cells and hypothalamic and brainstem neurons from spontaneously hypertensive rats: Possible implications in hypertension by Longo, Nadia Andrea et al.
RESEARCH ARTICLE
Tyrosine Hydroxylase Is Short-Term
Regulated by the Ubiquitin-Proteasome
System in PC12 Cells and Hypothalamic and
Brainstem Neurons from Spontaneously
Hypertensive Rats: Possible Implications in
Hypertension
Nadia A. Longo Carbajosa1, Gerardo Corradi1, María A. Lopez Verrilli1, María J. Guil2,
Marcelo S. Vatta2, Mariela M. Gironacci1*
1 Departamento de Química Biológica, IQUIFIB-CONICET, Facultad de Farmacia y Bioquímica, Universidad
de Buenos Aires, Buenos Aires, Argentina, 2 Cátedra de Fisiología, IQUIMEFA-CONICET, Facultad de
Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina
* mariela@qb.ffyb.uba.ar
Abstract
Aberrations in the ubiquitin-proteasome system (UPS) are implicated in the pathogenesis of
various diseases. Tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamines
biosynthesis, is involved in hypertension development. In this study we investigated wheth-
er UPS regulated TH turnover in PC12 cells and hypothalamic and brainstem neurons from
spontaneously hypertensive rats (SHR) and whether this system was impaired in hyperten-
sion. PC12 cells were exposed to proteasome or lysosome inhibitors and TH protein level
evaluated by Western blot. Lactacystin, a proteasome inhibitor, induced an increase of
86±15% in TH levels after 30 min of incubation, then it started to decrease up to 6 h to reach
control levels and finally it rose up to 35.2±8.5% after 24 h. Bafilomycin, a lysosome inhibi-
tor, did not alter TH protein levels during short times, but it increased TH by 92±22% above
basal after 6 h treatment. Before degradation proteasome substrates are labeled by conju-
gation with ubiquitin. Efficacy of proteasome inhibition on TH turnover was evidenced by
accumulation of ubiquitinylated TH after 30 min. Further, the inhibition of proteasome in-
creased the quantity of TH phosphorylated at Ser40, which is essential for TH activity, by
2.7±0.3 fold above basal. TH protein level was upregulated in neurons from hypothalami
and brainstem of SHR when the proteasome was inhibited during 30 min, supporting that
neuronal TH is also short-term regulated by the proteasome. Since the increased TH levels
reported in hypertension may result from proteasome dysfunction, we evaluate proteasme
activity. Proteasome activity was significantly reduced by 67±4% in hypothalamic and brain-
stem neurons from SHR while its protein levels did not change. Present findings show that
TH is regulated by the UPS. The impairment in proteasome activity observed in SHR neu-
rons may be one of the causes of the increased TH protein levels reported in hypertension.
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Introduction
Cellular protein degradation is a highly complex, temporally controlled, and tightly regulated
process that plays a critical role in a variety of basic pathways not only during cell life and
death but also in health and disease. The ubiquitin-proteasome system (UPS) is the major
pathway for intracellular protein degradation in eukaryotic cells [1,2]. Degradation of proteins
by the UPS occurs in two successive steps: 1) conjugation of multiple ubiquitin (Ub) moieties
to the substrate and 2) degradation of the tagged protein by the downstream 26S proteasome
complex. This complex is composed of a 20S core particle which embodies the catalytic activity
and two 19S regulatory particles [1,2]. Attachment of Ub is the dominant mechanism to tag
proteins for degradation by the 26S proteasome and involves the activity of three types of en-
zymes: E1 ubiquitin–activating enzyme, E2 ubiquitin–carrier enzyme and E3 ubiquitin–protein
ligase. The sequential action of these enzymes leads to conjugation of Ub to proteins. Different
E3 ligase target specific substrates for degradation and its activity could be under local control
depending on the presence of regulatory cofactors [1,3–5].
Alterations in the UPS are implicated in the pathogenesis of cancer, neurodegenerative and
immune diseases [1–5] and further, the UPS has been recognized as a key regulatory pathway
in cardiovascular diseases [6–8]. Recent evidence also shows that the UPS modulates the
activity of endothelial nitric oxide synthase, the major enzyme involved in vascular homeosta-
sis which by interacting with other vasoactive mediators and influencing the oxidative stress re-
sponse in the vasculature contributes to the regulation of endothelial (dys)function [7–9].
L-tyrosine hydroxylase (EC 1.14.16.2) (TH) is the first enzyme and rate-limiting step in cate-
cholamine biosynthesis that catalyzes the conversion of L-tyrosine to L-dihydroxyphenylalanine
[10]. Increased catecholaminergic neurotransmission has been reported in spontaneously hyper-
tensive rats (SHR), characterized by increased TH activity as well as gene and protein expression
[11–13], suggesting that TH plays a key role in genesis, development and/or maintenance of hy-
pertension. In fact, Rao et al. [14] have reported that common variation in the TH proximal pro-
moter contributes to inheritable alteration in multiple autonomic traits, biochemical and
physiological, and the ultimate disease trait of hypertension.
TH activity is regulated by two mechanisms: short-term direct regulation of enzyme activity
(allosteric regulation, catecholamin feedback inhibition and phosphorylation) and medium- to
long-term regulation of gene transcription [10]. In addition, enzyme activity is also regulated
through its turnover. The half-life of rat TH has been reported to be 17 h [15], 30 h [16] and
29 h [17] in PC12 cells, in a subclone of PC12 cells and in chromaffin cells, respectively. In ad-
dition, Nakashima et al. [18] reported that no TH degradation by the proteasome occurs in
PC12 cells at times around 8 h, but times smaller than 4 h were not evaluated. Our aim was to
investigate whether TH is short-term modulated by the UPS. Given that aberrations in the
UPS are implicated in the pathogenesis of many diseases, and that TH protein levels and activi-
ty are augmented in SHR, which may be a consequence of impairment in the UPS activity, we
investigated proteasome activity and protein levels centrally in SHR.
Materials and Methods
Reagents
Fetal bovine serum, penicilin-streptomycin, goat anti-mouse antibody coupled to Alexa 594,
goat anti-rabbit antibody coupled to Alexa 488 and Dulbecco’s modified Eagle’s medium
(DMEM) were purchased from Invitrogen (Carlsbad, CA, USA). Rabbit anti-Ub antibody was
from Santa Cruz Biotechnology Laboratories (Santa Cruz, CA, USA). Bovine seroalbumin
(BSA), paraformaldehyde (PFA 4%), phosphate buffered saline (PBS) and the protease
Tyrosine Hydroxylase Regulation by the Ubiquitin-Proteasome System
PLOSONE | DOI:10.1371/journal.pone.0116597 February 24, 2015 2 / 18
MMG are career researchers from CONICET. The
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
inhibitors cocktail were from Sigma Chemical Co. (St. Louis, MO, USA). Polyclonal anti-TH
rabbit, monoclonal anti-TH mouse, anti-TH phosphoSer-19 rabbit and anti-TH phosphoSer-
40 rabbit antibodies were from Chemicon (San Francisco, CA, USA). Phosphatase inhibitor,
ubiquitinated protein enrichment kit, proteasome substrate III Suc-Leu-Leu-Val-Tyr-amino-
methyl coumarin (Suc-LLVY-AMC) and monoclonal anti-20S proteasome alfa1,2,3,5,6&7-
subunits mouse antibody were from Calbiochem (EMD Chemicals, Gibbstown, USA).
Animals
Three-months old male Wistar-Kyoto (WKY) and SHR rats were used in the present work.
The animals were housed in cages, with a 12-hour light/dark cycle, controlled temperature and
humidity. All animals were given water and food ad libitum (commercial rodents Purina chow,
Cooperacion SRL, Argentina).
Mean arterial blood pressure measurement
A guide cannula was placed in the rat brain left lateral ventricle. Briefly, animals under anaes-
thesia (50 mg/kg ketamine plus 10 mg/kg xylazine) were mounted in a stereotaxic apparatus
(Kopf model 900, David Kopf Instruments, USA) and a small hole was drilled through the
skull. An intracranial cannula was placed into the left lateral ventricle by using appropriate ste-
reotaxic coordinates [19]. The cannula was secured by two screws inserted into the surface of
the bone using cyanoacrylate. Rats were placed in individual cages and allowed to recover
from surgery. Seven days after surgery, WKY and SHR rats were anesthetized with urethane
(1.2 g/kg of body weight) and the femoral artery cannulated. A catheter was connected to a
pressure transducer and signals recorded in a AD Instruments apparatus (Power Lab 8/30).
Following 20 min stabilization period, artificial cerebrospinal fluid (aCSF) or MG-132 (20 μM,
1 μl/min) was injected in the lateral ventricle and systolic and diastolic pressures as well as car-
diac rate were recorded for 60 min. MG-132 is an agent substrate analogues and potent transi-
tion-state inhibitor primarily of the chymotrypsin-like activity of the proteasome, reversible
and with high cell penetration [20]. The dose of MG-132 was chosen according to previous
studies [21].
Cell culture
PC12 cells, a rat adrenal pheochromocytoma cell line which expresses catecholaminergic
neuronal properties [22], were grown in DMEM high glucose supplemented with 5% heat
inactivated fetal bovine serum, 10% horse serum and penicilin-streptomycin at 37 C in a hu-
midified atmosphere at 95% air and 5% CO2. Cells were serum-starved 24 h prior to treatment.
PC12 cells were a gift from Dr. Sandra Verstraeten who acquired them from ATTC (USA).
Neuronal cultures were obtained from hypothalamus-brainstem areas of 1-day-old WKY
and SHR rats and cells were used after 8–10 days in culture as previously reported [12].
Cell viability was evaluated in cells exposed to different treatments as describe by Uludag
and Sefton [23].
The proteasome inhibitor lactacystin was used at a concentration of 1 or 5 μmol/L as previ-
ously reported [12].
TH protein measurement
TH protein level was measured by Western blot [12]. Membranes were subsequently probed
with either mouse anti-TH (1:500) to measure TH protein level or with rabbit anti-TH phos-
phoSer-19 (1:300) or anti-TH phosphoSer-40 (1:300) to meassure TH phosphorylation,
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followed by incubation with goat anti-mouse or goat anti-rabbit IgGs coupled to horseradish
peroxidase (Amersham Biosciences, Piscataway, NY, USA). Immunoreactive bands were visu-
alized by chemiluminescence detection (ECL Plus reagent, Amersham Biosciences, Piscataway,
NY, USA) and quantified by densitometry. Protein loading was evaluated by reblotting
membranes with anti-GAPDH antibody.
TH ubiquitination
Cells were incubated in the absence or presence of the proteasome inhibitor and Ub-TH was
isolated with an ubiquitylated protein enrichment kit which binds ubiquitylated cellular pro-
teins (Calbiochem). Proteins were resolved in a 4–12% SDS-PAGE and Ub-TH protein level
was evaluated by Western-blot as described above using a mouse anti-TH antibody (dilution
1/500). Membranes were reprobed with a rabbit anti-Ub antibody (dilution 1/500) to further
confirm the efectiveness of the ubiquitylated protein enrichment kit.
Immunocytochemistry
Cells were fixed in 4% PFA and immunostained as previously described [24]. Cells were incu-
bated with either rabbit anti-TH antibody (1:500) plus mouse anti-proteasome antibody
(1:250) or mouse anti-TH antibody (1:1000) plus rabbit anti-Ub antibody (1:150) or either rab-
bit anti-TH phosphoSer-19 (1:300) or anti-TH phosphoSer-40 anti-TH antibody (1:500) plus
mouse anti-proteasome antibody (1:250) in PBS-T 90 min at room temperature. Cells were in-
cubated with anti-rabbit antibody coupled to Alexa 488 (1:500) and anti-mouse IgG Alexa-
Fluor 594 (1:600) for 1 h at room temperature. Nonspecific staining was measured in cells
treated with blocking solution in the absence of the primary antibody. Samples were mounted
and imaged using an Olympus Fluoview FV1000 spectral laser scanning confocal microscope
with a 60x oil immersion lens using dual excitation (473 nm for Alexa 488 and 559 nm for
Alexa 594). Due to the spectral properties of the scan head, fluorescence emission was collected
between 510 and 550 nm for Alexa 488 and 600–660 nm for Alexa 594. Images were obtained
using sequential scanning for each channel to eliminate the cross-talk of chromophores.
Quantitative colocalization was estimated by Pearson´s correlation coefficient and overlap
coefficient according to Manders [25], which were calculated using Image-Pro Plus software
(MediaCybernetics Inc.).
26S Proteasome activity
Proteasome activity was evaluated in the hypothalamus and brainstem as well as in primary
neuronal cultures from these brain areas of WKY or SHR rats. The study was performed in
these brain areas given their relevance in the control of cardiovascular function, and further we
have previously reported that angiotensin-(1–7) regulates TH expression through the UPS sys-
tem in neuronal cultures from rat hypothalamus and brainstem [12]. Rats were euthanized by
decapitation and the hypothalamus and brainstem removed. Tissues or neuronal cells were
homogenized in ice cold buffer (pH 7.4) containing 25 mmol/L Hepes, 1 mmol/L EDTA,
0.32 mol/L sucrose and centrifuged at 14000 xg at 4°C for 15 min. The supernatant was used to
assay 26S proteasome activity by measuring ATP-dependent degradation of the proteasome
fluorescence substrate III Suc-LLVY-AMC as previously described [26]. Briefly, lysates were in-
cubated at 37°C in incubation buffer (50 mmol/L Tris-HCl, pH 7.5, 40 mmol/L KCl, 5 mmol/L
MgCl2, 1.1 mMDTT, 0.5 mg/mL BSA and 0.5 mmol/L ATP), and 0.1 mmol/L Suc-Leu-Leu-
Val-Tyr AMC. AMC hydrolysis was quantified in a spectrofluorometer (Aminco Bowman
Series 2) at 380 nm excitation and 460 nm emission wavelengths. Enzymatic activity was
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normalized to protein concentration and expressed as % of change with respect to the enzy-
matic activity in WKY rats.
Proteasome protein level measurement
Proteasome protein level was measured by Western blot in the hypothalamus and brainstem as
well as in primary neuronal cultures from the hypothalamus and brainstem of WKY or SHR
rats as described above using a monoclonal anti-20S proteasome alfa1,2,3,5,6&7-subunits
mouse antibody (Calbiochem) (1/1000).
Ethics Statement
This study was carried out in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals (NIH Publication No. 85-23, 1985, revised 1996). The
protocol was approved by the Institutional Animals Care and Use Committee of the School
of Pharmacy and Biochemistry, University of Buenos Aires, Argentina (permit number
031013-5).
Statistical analysis
The data are presented as mean ± SEM. Statistical significance was assessed by Student-t-test
or one-way analysis of variance (ANOVA) followed by Bonferroni post tests (GraphPad Prism
4, GraphPad Software, Inc.). P values<0.05 were considered statistically significant.
Results
TH is short-term regulated by the UPS
Fig. 1A shows the effect of lactacystin, a specific proteasome inhibitor, on TH levels in PC12
cells. Time dependent experiments with 1 μmol/L lactacystin showed that TH increased by
86±15% at 30 min, then decreased to reach basal levels at 6 h but then augmented up to
45.2±8.5% following 24 h (Fig. 1A). These findings suggest that proteasome regulates TH pro-
tein level, at short and long time periods.
As the decrease in TH at 6 h may involve another degradating pathway such as lysosomes,
cell were exposed to bafilomycin, an inhibitor of H+-ATPase, the enzyme that maintains the
acidic pH within lysosomes. Bafilomycin (5 nmol/L) did not alter TH protein content at short
times, but it significantly increased the enzyme by 92±22% after 6 h treatment (Fig. 1B).
None of the treatments affected cell viability before 12 h but after 24 h incubation with the
proteasome inhibitor cell viability declined 35±5% (data not shown).
Proteasome can degrade poly- [3] or mono- [27,28] or even unubiquitylated proteins [29].
As proteasome substrates are generally tagged with ubiquitin before degradation [3], we ad-
dressed whether TH was ubiquitylated before it was recognized by the proteosome. PC12 cells
were incubated in the presence or absence of lactacystin during 30 min and Ub-TH content
was determined. We focused our study at a short time (30 min) because TH turnover at longer
times (more than 12 h) have been investigated [15–17]. As it is shown in Fig. 2, TH was mono-
ubiquitylated and the efficacy of proteasome inhibition on TH turnover in PC12 cells was
evidenced by ubiquitylated TH accumulation after exposure to the proteasome inhibitor for
30 min, supporting that TH is ubiquitylated before being degraded by the proteasome. To fur-
ther confirm this result, the colocalization of TH with either Ub or the proteasome 26S was
evaluated. Fig. 3 shows that TH colocalized with both Ub and proteasome.
TH activity can be regulated by protein phosphorylation at serine (Ser) residues by diverse
protein kinases [30]. Phosphorylation of TH at Ser-19 site has no effect on TH activity,
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Fig 1. Effect of proteasome and lysosome inhibition on TH protein level. PC12 cells were treated with 1 μmol/L lactacystin (A), a specific proteasome
inhibitor, or 5 nmol/L bafilomycin (B), a H+-ATPase inhibitor, at different times and TH protein level assessed byWestern-blot as described under Methods.
The blots were stripped and reprobed for GAPDH to assess protein loading. Signals from TH protein level were normalized to GAPDH levels. Each bar
represents the mean ± SEM of 3 determinations from four separate cell culture preparations. * P< 0.05 as compared to basal.
doi:10.1371/journal.pone.0116597.g001
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althouth it alters the enzyme conformation allowing increased accessibility of Ser-40 to kinases
leading to enhanced enzyme activity [30,31]. As shown in Fig. 4, phosphorylation of TH at Ser-
19 and Ser-40 sites was increased by 5.6±1.7 and 2.7±0.3 fold above basal, respectively, when
PC12 cells were exposed to 1 μmol/L lactacystin for 30 min, suggesting that the phosphorylated
TH is accumulated as a result of proteasome inhibition. In addition, phosphorylated TH at
Ser19 or Ser40 colocalized with the proteasome in PC12 cells (Fig. 5).
Altogether these results suggest that TH is short-term regulated by the UPS in PC12 cells.
We also investigated the involvement of the UPS on TH turnover in neurons. Neuronal cul-
tures from the hypothalamus and brainstem of WKY or SHR were exposed to the proteasome
inhibitor for 30 min and TH protein content assessed. Results showed that TH protein content
was increased above basal in neurons fromWKY and SHR when the proteasome was inhibited
supporting that TH protein content is effectively centrally regulated by the UPS (Fig. 6).
Proteasome activity is impaired in hypertension
As the increase in TH protein content reported by others and us in neurons from SHR [12, 13]
may result from impaired UPS activity, we investigated proteasome activity and protein con-
tent in SHR brain areas related to blood pressure regulation. Fig. 7A shows that TH protein
content was increased in SHR hypothalamus and brainstem compared to its normotensive
control. Increased THmay be correlated with enhanced TH activity in the hypothalamus and
Fig 2. TH ubiquitination. PC12 cells were incubated for 30 min in the absence (basal) or presence of lactacystin (Lacta) (1 μmol/L). Ub-TH was
immunoprecipitated with an ubiquitinated protein enrichment kit (IP: anti-Ub). Proteins were resolved in a 4–12% SDS-PAGE and Ub-TH protein level
assessed byWestern-blot as described under Methods. The same membrane was stripped and reprobed with an antibody against ubiquitin (Ub) to further
corroborate that Ub-proteins were isolated with the kit. Three separate experiments were performed. A representative Western blot immunoblotted with
antibodies directed against TH or Ub is shown.
doi:10.1371/journal.pone.0116597.g002
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elevated blood pressure as previously reported in SHR [11, 12]. Since the proteasome regulates
TH protein levels, it may consequently affect blood pressure in SHR. Thus, we evaluated the ef-
fect of proteasome inhibition on blood pressure. Intracerebroventricular injection of the pro-
teasome inhibitor induced a significant increase in blood pressure in WKY and SHR, being
this increase greater in SHR (5.3±1.6 mmHg increase in WKY vs 21.0±2.0 mmHg in SHR)
(Fig. 7B). This result shows that proteasome inhibition in WKY rats leads to hypertension re-
producing the SHR phenotype.
We next addressed whether the activity and expression of the proteasome were modified in
SHR.
Proteasome activity was diminished in the SHR hypothalamus as compared to WKY where-
as the protein content was not modified (Fig. 8A). Similarly, proteasome activity was dimin-
ished whereas its protein level was not modified in the brainstem of SHR (Fig. 8B). Proteasome
activity was also measured in a tissue not involved in blood pressure regulation. Proteasome
Fig 3. Colocalization of TH with ubiquitin or proteasome in PC12 cells.Cells were incubated with either mouse anti-TH plus rabbit anti-ubiquitin
antibodies (upper panel) or rabbit anti-TH plus mouse anti-proteasome antibodies (lower panel) followed by incubation with a anti-rabbit antibody coupled to
Alexa 488 and anti-mouse coupled to AlexaFluor 594. See text for details. Scale bar = 5 μm. Three separate cell culture preparations were performed and 10
different images were taken and analyzed for each experiment. One representative image is presented.
doi:10.1371/journal.pone.0116597.g003
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Fig 4. Effect of proteasome inhibition on TH phosphorylation at Ser19 (A) and Ser40 (B). PC12 cells
were exposed to 1 μmol/L lactacystin at different times and TH-phospho Ser19 or TH-phospho Ser40 were
measured byWestern-blot as described in Methods and normalized to TH protein level in the same sample.
Protein loading was evaluated by reblotting the membrane with anti-GAPDH antibody and no differences
Tyrosine Hydroxylase Regulation by the Ubiquitin-Proteasome System
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activity was not significantly different from SHR lungs compared to WKY (data not shown),
suggesting that proteasome dysfunction is related to tissues involved in blood pressure control.
Since TH is endogenously expressed in neurons and is increased in hypertension [12,13],
we investigated whether the proteasome dysfunction observed in the hypothalamus and brain-
stem from SHR was also evident in neurons. As it is shown in Fig. 8 (C), proteasome protein
content was not modified in neuronal cultures from SHR as compared to its normotensive con-
trol, but proteasome activity was significantly reduced by 67±4%.
These findings support a proteasome dysfunction in hypothalamus and brainstem of SHR.
Discussion
Present findings show that the blockade of the proteasome up-regulates TH protein content as
well its phosphorylation at the Ser 40 site, which is essential for full activation of the enzyme.
The up-regulation of TH by proteasome inhibition was evident at 30 min and after 12 h
were observed in any of the conditions assayed. Each bar represents the mean ± SEM of 3 determinations
from four separate cell culture preparations. * P< 0.05 as compared to basal.
doi:10.1371/journal.pone.0116597.g004
Fig 5. Colocalization of phospho-Ser40-TH (P-Ser 40 TH) or phospho-Ser19-TH (P-Ser 19 TH) with proteasome in PC12 cells. Cells were incubated
with either rabbit phospho-Ser40-TH plus mouse proteasome antibodies (upper panel) or rabbit phospho-Ser19-TH plus mouse proteasome antibodies
(lower panel) followed by incubation with an anti-rabbit antibody coupled to Alexa 488 and anti-mouse coupled to AlexaFluor 594. See text for details. Scale
bar = 5 μm. Three separate cell culture preparations were performed and 10 different images were taken and analyzed for each experiment. One
representative image is presented.
doi:10.1371/journal.pone.0116597.g005
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Fig 6. TH protein level in neuronal cultures from hypothalami and brainstem of WKY or SHR incubated in the absence (control) or presence of the
proteasome inhibitor Lactacystin (5 μmol/L) (PI) during 30min. TH protein level was assessed byWestern-blot as described under Methods. Blots were
stripped and reprobed for GAPDH to assess protein loading. Signals from TH protein level were normalized to GAPDH levels. Each bar represents the
mean fcfc± SEM (n = 7). * P<0.05 as compared to each corresponding control.
doi:10.1371/journal.pone.0116597.g006
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Fig 7. TH protein level in the hypothalamus and brainstem of WKY or SHR rats. A, TH protein level was assessed byWestern-blot as described under
Methods. Blots were stripped and reprobed for GAPDH to assess protein loading. Signals from TH protein level were normalized to GAPDH levels. Each bar
represents the mean ± SEM (n = 7). * P< 0.05 as compared to WKY. B, Change in mean arterial pressure (MAP) in WKY and SHR after
intracerebroventricular injection of aCSF (control) or the proteasome inhibitor MG-132. Values are mean ±SEM (n = 7). * P< 0.05 as compared with basal.
doi:10.1371/journal.pone.0116597.g007
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Fig 8. A, Proteasome activity in the hypothalamus and brainstem of WKY and SHR rats. Values are mean ±SEM (n = 7). * P< 0.05 as compared with
WKY. B, Proteasome protein level in the hypothalamus and brainstem, respectively, fromWKY and SHR. Proteasome protein level was measured by
Western-blot as described under Methods. Blots were stripped and reprobed for GAPDH to assess protein loading. Signals from proteasome protein level
were normalized to GAPDH levels. Values are mean ±SEM (n = 7). * P< 0.05 as compared to WKY. C, Proteasome protein level and activity in neuronal
cultures from the hypothalamus and brainstem of WKY and SHR rats. Values are mean ±SEM of 3 determinations from three separate cell culture
preparations. * P< 0.05 as compared with WKY.
doi:10.1371/journal.pone.0116597.g008
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whereas by lysosome inhibition it was observed at 6 h suggesting that the proteasome is in-
volved in the short-term regulation of TH whereas lysosomes at longer times. Furthermore,
our present work shows that the proteasome activity was decreased in hypothalamic and brain-
stem neurons of SHR, and this may account for the increase in central TH activity and expres-
sion previously reported in SHR [12,13].
TH, the enzyme that catalyzes the first and rate-limiting step in cathecolamines biosynthe-
sis, is localized in presynaptic cathecolaminergic neurons [10]. Several evidence support the
relevance of the UPS in neurons [5,32]. The formation and maintenance of specialized neuro-
nal structures and neuronal activity is known to involve local protein degradation controlled
by Ub conjugation. A main function of the presynaptic compartment is the release of specific
neurotransmitters from presynaptic vesicles into the synaptic cleft upon neuronal activation.
Several evidence show that presynaptic processes are also under the control of local ubiquitin-
dependent regulation pathways. In this sense, enzymes of the UPS localize to presynaptic bou-
tons in Drosophila, and the inhibition of the 26S proteasome elevates synaptic transmission.
One known presynaptic target of the UPS is Dunc13, which is important for synaptic vesicle
fusion [32].
TH turnover is around 17 h [15]. In agreement, an increase in TH protein levels was ob-
served when the proteasome was inhibited for more than 12 h (present results). However, pres-
ent findings also show that TH was short-term regulated by the UPS, given that following
30 min cell exposure to proteasome inhibition, an increase in TH protein level, phosphoryla-
tion and ubiquitination, a tag necessary to be recognized for the proteasome, was observed. In
accordance, TH short-term regulation by the UPS was also observed in neurons from the hypo-
thalamus and brainstem of SHR (present results). In a previous study, Nakashima et al. [18] re-
ported that no changes in protein levels were observed with proteasome activity blockade. The
discrepancy with our study may arise from the different time experimental protocols used.
While that study was conducted at two time points (4 and 8 h), our study was performed from
30 min to 24 h. However, at 6 h our results are similar to those reported by Nakashima et al.
[18], that is, no TH protein level regulated by the proteasome, because at this time, according
to our results, lysosome regulate TH protein content.
Proteins targeted for proteasome degradation are tagged with Ub [3]. A polyubiquitin chain
anchored to the substrate has been long stated for proteasomal recognition. However, several
recent studies have demonstrated that monoubiquitylation or multiple monoubiquitylation
can be sufficient for efficiently targeting certain substrates for proteasomal degradation
([27,28,33]). Proteins not only shorter but also larger than 150 residues can be degraded by the
proteasome when monoubiquitylated. For instance, monoubiquitylation of paired box 3, an
important regulator of muscle differentiation, or multiple monoubiquitylation events on
phospholipase D target these proteins containing more than 150 residues for proteasomal deg-
radation [33]. Our results show that TH is a substrate for the Ub-conjugating enzyme, being
mono-ubiquitylated prior to its degradation by the proteasome. In accordance, the mono-
ubiquitylation of TH has been shown in the catecholamine storage/secretory granules of the
adrenal medulla [34]. Ub-TH has been reported both in vitro as a soluble recombinant human
enzyme and in vivo as a membrane-bound form of the enzyme in the catecholamine storage/
secretory granules of the adrenal medulla [34]. The integral TH of the bovine adrenal chroma-
fin granule membrane was detected mainly as mono-ubiquitylated. In contrast, multi/poly Ub
conjugates were observed for the soluble recombinant human TH in the reticulocyte lysate
system [34].
Most degradation by the proteasome depends on ubiquitin conjugation. However, for a
significant subset of proteins turnover is independent of ubiquitin conjugation. For instance,
Rpn4, a transcriptional regulator of proteasome homeostasis, thymidylate synthase, an enzyme
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required for production of DNA precursors and ornithine decarboxylase, the initial enzyme
committed to polyamine biosynthesis, have been reported to be degraded in a Ub-independent
manner [29].
TH activity can be regulated by protein phosphorylation at serine (Ser) residues by a variety
of protein kinases [30]. Phosphorylation of TH at Ser-19 has no effect on TH activity but
changes the enzyme conformation facilitating the accessibility of Ser-40 to kinases so leading
to an increase in the enzyme activity [30,31]. Phosphorylation of Ser-40 results in at least 20-
fold activation of TH. Phosphorylation at Ser-31 also increases TH activity but to a much lesser
extent than for Ser-40 phosphorylation [30,31,35,36], thus we only measured phosphorylation
at Ser-40. Our study shows that proteasome inhibition induced an increase in the levels of TH
phosphorylated at Ser19 and Ser40, suggesting that not only TH protein level but also TH ac-
tivity may be modulated by the UPS. We should point out that in the present study we did not
measure TH activity, but instead we evaluated TH phosphorylation as TH activation index
measurement. In accordance with our present study, a recent work showed that the inhibition
of proteasome activity increases the quantity of TH molecules phosphorylated at their Ser19
and Ser40 [18]. In addition, Kawahata et al. [37] have shown that 12 to 48 h proteasomal inhi-
bition leads to accumulation of insoluble phospho-Ser40-TH and formation of phospho-
Ser40-TH-containing intracellular aggregates which tightly co-localized with Ub, suggesting
that phospho-Ser40-TH is prone to be insolubilized and aggregated by dysfunction of an UPS
in PC12D cells.
The pathological states associated with the UPS can be classified into two groups: 1) those
that result from loss of function, mutation in a ubiquitin system enzyme or target substrate,
that result in stabilization of certain proteins and 2) those that result from gain of function,
abnormal or accelerated degradation of the protein target [1,3]. In the present work a loss of
proteasome function was observed in the hypothalamus and brainstem from hypertensive rats
and this observation is not only limited to hypertension. Proteasomal dysfunction, which
would induce an accumulation and aggregation of cytoplasmic proteins, may be one of the
causes of neurodegenerative disorders [1,4,5]. UPS aberrations may contribute not only to the
pathogenesis of neurodegenerative disorders, several evidence suggest that insulin-resistance,
diabetes, endothelial dysfunction, atherosclerosis and cardiovascular diseases share in common
a deregulation of the UPS [6,7,9,38–40]. Taking into account this evidence, the increased TH
protein content and activity reported in hypothalamic neurons from SHR [12,13] may be asso-
ciated with UPS activity impairment. In the present work, a decrease in proteasome activity
was observed in neurons from the hypothalamus and brainstem from SHR, despite the fact
that proteasome protein level was not changed in this pathological situation. This impairment
in proteasome activity may be responsible for the increased TH protein level in SHR. Further,
the impairment in the neuronal UPS system observed in this present work may affect the turn-
over of others proteins, favoring their accumulation. It is important to note that the CNS of
SHR displays abnormal features compared to normotensive rats [41]. In the phase of estab-
lished hypertension these rats develop brain atrophy, loss of nerve cells, and glial reaction, a
phenomena shared to some extent with hypertensive brain damage in humans. An altered ana-
tomical organization of hypothalamic regions and gross morphological brain differences be-
tween SHR and age-matched normotensive WKY rats were reported. The hippocampus, a key
area for learning and memory, is smaller in SHR compared with that in normotensive cohorts,
as well as the density of nuclei in the CA1 subfield. In fact, these rats presents memory and
learning impairment. From a neurotransmitter point of view, they present changes of some
specific neurotransmitter systems that may have functional and behavioral relevance. An im-
paired cholinergic neurotransmission characterizes SHR, similar to those reported in patients
affected by vascular dementia. SHR are also characterized by a dopaminergic hypofunction
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and noradrenergic hyperactivity similarly as occurs in attention-deficit with hyperactivity dis-
order [41]. These noradrenergic hyperactivity may be correlated with proteasome dysfunction
observed in hypothalamus and brainstem (present results).
In conclusion, present findings show that TH protein level is not only long-term but also
short-term regulated by the UPS and that the enzyme is ubiquitylated prior to its degradation
by the proteasome. Furthermore, proteasome activity is impaired in SHR. The fact that blood
pressure increases in SHR after proteasome inhibition suggest that the decreased proteasome
activity is not saturated in SHR, and therefore may not represent the only key mechanism in
hypertension. Alterations in the proteasome activity may be one of the causes of the increased
TH levels reported in hypertension. Improper regulation of TH content due to malfunctioning
of the stabilization mechanism could lead to profound changes in catecholamine levels, thus af-
fecting behavior and cardiovascular responses controlled by the central nervous system.
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